ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,949,134 | +1.9% | 10,133 | -2.5% | 0.06% | -3.3% |
| Q1 2023 | $3,874,087 | -1.6% | 10,398 | 0.0% | 0.06% | -7.6% |
| Q4 2022 | $3,939,074 | +6.8% | 10,398 | -0.5% | 0.07% | +3.1% |
| Q3 2022 | $3,689,000 | -8.3% | 10,448 | -1.6% | 0.06% | -1.5% |
| Q2 2022 | $4,025,000 | +17.9% | 10,623 | -1.9% | 0.06% | +35.4% |
| Q1 2022 | $3,414,000 | -47.3% | 10,828 | -41.5% | 0.05% | -40.7% |
| Q4 2021 | $6,479,000 | +14.4% | 18,500 | -1.3% | 0.08% | +2.5% |
| Q3 2021 | $5,661,000 | +1.5% | 18,745 | +1.2% | 0.08% | +1.3% |
| Q2 2021 | $5,578,000 | +14.3% | 18,528 | +4.5% | 0.08% | +2.6% |
| Q1 2021 | $4,881,000 | -13.9% | 17,725 | -8.0% | 0.08% | -17.4% |
| Q4 2020 | $5,666,000 | +8.2% | 19,267 | -3.4% | 0.09% | -5.2% |
| Q3 2020 | $5,235,000 | +639.4% | 19,940 | +534.0% | 0.10% | +592.9% |
| Q2 2020 | $708,000 | – | 3,145 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |